Literature DB >> 24165035

Glycosphingolipids: synthesis and functions.

Giovanni D'Angelo1, Serena Capasso, Lucia Sticco, Domenico Russo.   

Abstract

Glycosphingolipids (GSLs) comprise a heterogeneous group of membrane lipids formed by a ceramide backbone covalently linked to a glycan moiety. Hundreds of different glycans can be linked to tens of different ceramide molecules, giving rise to an astonishing variety of structurally different compounds, each of which has the potential for a specific biological function. GSLs have been suggested to modulate membrane-protein function and to contribute to cell-cell communication. Although GSLs are dispensable for cellular life, they are indeed collectively required for the development of multicellular organisms, and are thus considered to be key molecules in 'cell sociology'. Consequently, the GSL make-up of individual cells is highly dynamic and is strictly linked to the cellular developmental and environmental state. In the present review, we discuss some of the available knowledge, open questions and future perspectives relating to the study of GSL biology.
© 2013 FEBS.

Entities:  

Keywords:  glycocode; glycosphingolipids; golgi complex; sphingolipids

Mesh:

Substances:

Year:  2013        PMID: 24165035     DOI: 10.1111/febs.12559

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  95 in total

1.  Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic.

Authors:  Tove Irene Klokk; Simona Kavaliauskiene; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

2.  Functional analyses of the UDP-galactose transporter SLC35A2 using the binding of bacterial Shiga toxins as a novel activity assay.

Authors:  Danyang Li; Somshuvra Mukhopadhyay
Journal:  Glycobiology       Date:  2019-06-01       Impact factor: 4.313

3.  Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Methods Mol Biol       Date:  2021

4.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  Glycosphingolipid metabolic reprogramming drives neural differentiation.

Authors:  Domenico Russo; Floriana Della Ragione; Riccardo Rizzo; Eiji Sugiyama; Francesco Scalabrì; Kei Hori; Serena Capasso; Lucia Sticco; Salvatore Fioriniello; Roberto De Gregorio; Ilaria Granata; Mario R Guarracino; Vittorio Maglione; Ludger Johannes; Gian Carlo Bellenchi; Mikio Hoshino; Mitsutoshi Setou; Maurizio D'Esposito; Alberto Luini; Giovanni D'Angelo
Journal:  EMBO J       Date:  2017-12-27       Impact factor: 11.598

6.  ACBD3 is required for FAPP2 transferring glucosylceramide through maintaining the Golgi integrity.

Authors:  Jing Liao; Yuxiang Guan; Wei Chen; Can Shi; Dongdong Yao; Fengsong Wang; Sin Man Lam; Guanghou Shui; Xinwang Cao
Journal:  J Mol Cell Biol       Date:  2019-02-01       Impact factor: 6.216

Review 7.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

8.  DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.

Authors:  Jiangzhou Peng; Baishen Chen; Zhuojian Shen; Heran Deng; Degang Liu; Xuan Xie; Xiangfeng Gan; Xia Xu; Zhiquan Huang; Ju Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

Review 10.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.